Test Compendium
Test Compendium is your definitive resource for detailed information on a wide array of diagnostic tests. Each entry in our compendium is meticulously cataloged to aid healthcare providers in selecting and interpreting the right tests for their patients.
Displaying 326 - 350 of 475
Concurrent DeepSight™ Comprehensive 523 genes Liquid Biopsy (Somatic) + Neovare Portfolio testing (Germline)
MolecularConcurrent DeepSight™ Comprehensive 523 genes Liquid Biopsy (Somatic) + Neovare Portfolio testing (Germline) Methodology Molecular Test Description Disease Solid tumors; Breast cancer, Ovarian cancer,
Concurrent DeepSight™ on Liquid + siPortfolio Multi-Omics™ on Tissue
MolecularConcurrent DeepSight™ on Liquid + siPortfolio Multi-Omics™ on Tissue Methodology Molecular Test Description Disease Solid tumorsOn Tissue: siPortfolio Multi-Omics™ • NGS (500+ genes, TMB, MSI)
LymphoSight™
LymphoSight™ Test Description Probes/Genes IHC/CISH ALK1, BCL-1, BCL-2, BCL-6, BRAF, Bob1, CD2, CD3, CD4, CD5, CD7, CD8, CD10, CD15, CD20, CD21, CD23, CD25*, CD30, CD43, CD79a, CD138, C-MYC, EBV-LMP, Granzyme B, ICOS*, IgA, IgG, IgG4, IgM, Kappa, Ki-67, Lambda, LEF1*, Mum1, OCT2, Pax5, Perforin, PD-1, TIA1. *: Pending CISH: EBER, Kappa,
CD5
Immunohistochemistry (IHC)CD5 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CD5 IHC Disease Marker for Chronic lymphocytic leukemia (CLL), mantle cell lymphoma (only rarely is CD5-), T cells (normal and malignant),
CD5/PAX5 (Dual)
Immunohistochemistry (IHC)CD5/PAX5 (Dual) Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CD5/PAX5 IHC Disease Identification of mature and immature B cell neoplasms, and Chronic lymphocytic leukemia (CLL)CD5/PAX5
CD56
Immunohistochemistry (IHC)CD56 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CD56 IHC Disease Marker of NK cells and NK lymphomas Detect residual myeloma and residual AML in bone marrow Differentiate
CD57
Immunohistochemistry (IHC)CD57 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CD57 IHC Disease Marker of NK cells and neuroendocrine tumors, helps distinguish high grade prostatic adenocarcinoma (CD57+) from
CD61
Immunohistochemistry (IHC)CD61 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CD61 IHC Disease Identify platelets,megakaryocytes, megakaryocytic leukemias, platelet thrombi Distinguish TTP (diffuse
CD68
Immunohistochemistry (IHC)CD68 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CD68 IHC Disease Histiocytic malignancies are usually CD68 positive. Histiocytic sarcoma Myeloid/monocytic sarcoma, differential
CD7
Immunohistochemistry (IHC)CD7 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CD7 IHC Disease T-cell leukemias and myeloid leukemias. CD7 can be aberrantly expressed in refractory anaemia with excess blasts
CD71
Immunohistochemistry (IHC)CD71 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CD71 IHC Disease Identifying erythroid precursors in red blood cell hypoplasia and hyperplasia, with or without dyspoietic features,
CD79a
Immunohistochemistry (IHC)CD79a Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CD79A IHC Disease General detection of B cells/B cell origin (with CD20); In ALL or small B cell lymphoproliferative disorders
CD8
Immunohistochemistry (IHC)CD8 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CD8 IHC Disease Marker of T cells (normal and malignant) Marker of cytotoxic/suppressor T cells Classify lymphomas Differentiate
CD99
Immunohistochemistry (IHC)CD99 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CD99 IHC Disease Small round blue cell tumors, Ewing sarcoma, lymphoblastic leukemias/lymphomas, round and spindle cell sarcomas,
CDX2
Immunohistochemistry (IHC)CDX2 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CDX2 IHC Disease GI origin for adenocarcinomas, metastatic adenocarcinoma, intestinal metaplasia of the stomach and intestinal-type
CEA (Monoclonal)
Immunohistochemistry (IHC)CEA (Monoclonal) Alternative Name CEA (Mono) Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CEAM IHC Disease Cholangiocarcinoma, colon cancer, cancers of the rectum, pancreas, prostate,
CEA (Polyclonal)
Immunohistochemistry (IHC)CEA (Polyclonal) Alternative Name CEA (Poly) Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CEAP IHC Disease Cholangiocarcinoma, colon cancer, cancers of the rectum, pancreas, prostate,
Chromogranin A
Immunohistochemistry (IHC)Chromogranin A Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CHROMO IHC Disease Neuroendocrine tumors, and pheochromocytomaGranin protein located in secretory vesicles of neurons
CK14
Immunohistochemistry (IHC)CK14 Alternative Name Cytokeratin 14 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CK14 IHC Disease Chronic lymphocytic leukemia (CLL), diffuse large cell lymphoma (DLBCL), follicular
CK17
Immunohistochemistry (IHC)CK17 Alternative Name Cytokeratin 17 (CK17, K17) Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CK17 IHC Disease Invasive or in situ ductal carcinoma of breast , bladder carcinoma,
CK19
Immunohistochemistry (IHC)CK19 Alternative Name Cytokeratin 19 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CK19 IHC Disease Bladder chordoma, CK19+ fragments is a poor prognostic factor for breast cancer,
CK20
Immunohistochemistry (IHC)CK20 Alternative Name Cytokeratin 20 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CK20 IHC Disease Mucinous ovarian tumors, intestinal adenocarcinoma, Merkel cell carcinomas, urothelial
CK5/6
Immunohistochemistry (IHC)CK5/6 Alternative Name Cytokeratin 5/6 and CK5. Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CK20 IHC Disease Epithelioid mesothelioma, colonic, urothelial and Merckel cell carcinomaBasic
CK7
Immunohistochemistry (IHC)CK7 Alternative Name Cytokeratin 7 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CK7 IHC Disease Adenocarcinoma of lung, breast, thyroid, endometrium, cervix, ovary, salivary gland,
CK903 (HMCK)
Immunohistochemistry (IHC)CK903 (HMCK) Alternative Name CK903 (34betaE12) Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CK903 IHC Disease Prostate cancerAlso called CK903, High molecular weight keratin relatively
CMV by IHC
Immunohistochemistry (IHC)CMV by IHC Alternative Name Cytomegalovirus Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CMV IHC Disease CMV related conditionsIdentification of cytomegalovirus infection
C-Myc by IHC
Immunohistochemistry (IHC)C-Myc by IHC Methodology Immunohistochemistry (IHC) Test Description Probes/Genes C-Myc IHC Disease Burkitt lymphomas (BL), Diffuse Large Cell LymphomaIHC for c-MYC overexpression (>40%) is used to
Congo Red
Special StainsCongo Red Methodology Special Stains Test Description Probes/Genes CONGO R SS Disease Systemic or localized amyloidosis, progression of multiple myeloma and other plasma cell dyscrasiasCongo red is a direct
